{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:27:18Z","timestamp":1791584838616,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zigong Key Science and Technology Program - Zigong Academy for Medical Big Data and Artificial Intelligence Joint Project","award":["2023-YGY-1-01"],"award-info":[{"award-number":["2023-YGY-1-01"]}]},{"name":"Zigong Heath Commission High-level Talent Science Project","award":["WJW-GCCRC026"],"award-info":[{"award-number":["WJW-GCCRC026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02060-7","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T09:35:38Z","timestamp":1772876138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pre-trigger risk scoring for moderate-to-severe ovarian hyperstimulation syndrome in in vitro fertilization and intracytoplasmic sperm injection cycles"],"prefix":"10.1186","volume":"19","author":[{"given":"Lina","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuming","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"6","key":"2060_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","volume":"8","author":"A Delvigne","year":"2002","unstructured":"Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. 2002;8(6):559\u201377. https:\/\/doi.org\/10.1093\/humupd\/8.6.559.","journal-title":"Hum Reprod Update."},{"issue":"4","key":"2060_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/uog.14684","volume":"45","author":"CO Nastri","year":"2015","unstructured":"Nastri CO, Teixeira DM, Moroni RM, Leitao VM, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention. Ultrasound Obstet Gynecol. 2015;45(4):377\u201393. https:\/\/doi.org\/10.1002\/uog.14684.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"2060_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/humrep\/deh638","volume":"20","author":"EG Papanikolaou","year":"2005","unstructured":"Papanikolaou EG, Tournaye H, Verpoest W, et al. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod (Oxford England). 2005;20(3):636\u201341. https:\/\/doi.org\/10.1093\/humrep\/deh638.","journal-title":"Hum Reprod (Oxford England)"},{"issue":"6","key":"2060_CR4","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1210\/jcem.80.6.7775647","volume":"80","author":"J Neulen","year":"1995","unstructured":"Neulen J, Yan Z, Raczek S, et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor\/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 1995;80(6):1967\u201371. https:\/\/doi.org\/10.1210\/jcem.80.6.7775647.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2060_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669\u201376. https:\/\/doi.org\/10.1038\/nm0603-669.","journal-title":"Nat Med"},{"issue":"2","key":"2060_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/0974-1208.86080","volume":"4","author":"P Kumar","year":"2011","unstructured":"Kumar P, Sait SF, Sharma A, Kumar M. Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011;4(2):70\u20135. https:\/\/doi.org\/10.4103\/0974-1208.86080.","journal-title":"J Hum Reprod Sci"},{"issue":"11","key":"2060_CR7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1055\/s-0038-1676059","volume":"40","author":"GAR de Maciel","year":"2018","unstructured":"Maciel GAR, Baracat EC, de Sa MFS. About the Anti-Mullerian Hormone (AMH) Uses in the Clinical Practice. Rev Bras Ginecol Obstet. 2018;40(11):661\u20133. Sobre os usos do Hormonio anti-Mulleriano na pratica clinica. https:\/\/doi.org\/10.1055\/s-0038-1676059.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"5","key":"2060_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/humupd\/dmu020","volume":"20","author":"SL Broer","year":"2014","unstructured":"Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688\u2013701. https:\/\/doi.org\/10.1093\/humupd\/dmu020.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2060_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humupd\/dmq034","volume":"17","author":"SL Broer","year":"2011","unstructured":"Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46\u201354. https:\/\/doi.org\/10.1093\/humupd\/dmq034.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"2060_CR10","doi-asserted-by":"publisher","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","volume":"296","author":"A Piouka","year":"2009","unstructured":"Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab Feb. 2009;296(2):E238\u201343. https:\/\/doi.org\/10.1152\/ajpendo.90684.2008.","journal-title":"Am J Physiol Endocrinol Metab Feb"},{"key":"2060_CR11","doi-asserted-by":"publisher","first-page":"6465903","DOI":"10.1155\/2018\/6465903","volume":"2018","author":"S Pinelli","year":"2018","unstructured":"Pinelli S, Basile S. Fertility preservation: current and future perspectives for oncologic patients at risk for iatrogenic premature ovarian insufficiency. Biomed Res Int. 2018;2018:6465903. https:\/\/doi.org\/10.1155\/2018\/6465903.","journal-title":"Biomed Res Int"},{"key":"2060_CR12","doi-asserted-by":"publisher","first-page":"911225","DOI":"10.3389\/fendo.2022.911225","volume":"13","author":"M Cao","year":"2022","unstructured":"Cao M, Liu Z, Lin Y, et al. A personalized management approach of OHSS: development of a multiphase prediction model and smartphone-based app. Front Endocrinol (Lausanne). 2022;13:911225. https:\/\/doi.org\/10.3389\/fendo.2022.911225.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2060_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/humrep\/deg208","volume":"18","author":"M Aboulghar","year":"2003","unstructured":"Aboulghar M. Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod (Oxford England). 2003;18(6):1140\u20131. https:\/\/doi.org\/10.1093\/humrep\/deg208.","journal-title":"Hum Reprod (Oxford England)"},{"issue":"2","key":"2060_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/14647273.2020.1809021","volume":"25","author":"A Sood","year":"2022","unstructured":"Sood A, Goel A, Boda S, Mathur R. Prediction of significant OHSS by ovarian reserve and ovarian response - implications for elective freeze-all strategy. Hum Fertil (Camb). 2022;25(2):390\u20136. https:\/\/doi.org\/10.1080\/14647273.2020.1809021.","journal-title":"Hum Fertil (Camb)"},{"issue":"2","key":"2060_CR15","doi-asserted-by":"publisher","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","volume":"2020","author":"T Ovarian Stimulation","year":"2020","unstructured":"Ovarian Stimulation T, Bosch E, Broer S, et al. ESHRE guideline: ovarian stimulation for IVF\/ICSI(dagger). Hum Reprod Open. 2020;2020(2):hoaa009. https:\/\/doi.org\/10.1093\/hropen\/hoaa009.","journal-title":"Hum Reprod Open"},{"issue":"1","key":"2060_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/s1472-6483(10)60042-9","volume":"19","author":"A Golan","year":"2009","unstructured":"Golan A, Weissman A, Symposium: update on prediction and management of OHSS. A modern classification of OHSS. Reproductive biomedicine online. 2009;19(1):28\u201332. https:\/\/doi.org\/10.1016\/s1472-6483(10)60042-9.","journal-title":"Reprod Biomed online"},{"issue":"1","key":"2060_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam EA-SPcwg","year":"2004","unstructured":"Rotterdam EA-SP. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod (Oxford, England). 2004;19(1):41\u20137. https:\/\/doi.org\/10.1093\/humrep\/deh098.","journal-title":"Jan"},{"issue":"4","key":"2060_CR18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.fertnstert.2025.01.008","volume":"123","author":"C Gracia","year":"2025","unstructured":"Gracia C, Brooks M, Goldstein J, Kalra S. How does American Society for Reproductive Medicine produce clinical guidelines? Fertil Steril. 2025;123(4):553\u201360. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.01.008.","journal-title":"Fertility sterility Apr"},{"issue":"2","key":"2060_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.fertnstert.2010.03.028","volume":"94","author":"P Humaidan","year":"2010","unstructured":"Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril. 2010;94(2):389\u2013400. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.03.028.","journal-title":"Fertil Steril"},{"issue":"6","key":"2060_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/humupd\/dmu062","volume":"21","author":"S Iliodromiti","year":"2015","unstructured":"Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015;21(6):698\u2013710. https:\/\/doi.org\/10.1093\/humupd\/dmu062.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2060_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.rbmo.2012.06.016","volume":"25","author":"M Munoz","year":"2012","unstructured":"Munoz M, Cruz M, Humaidan P, Garrido N, Perez-Cano I, Meseguer M. Dose of recombinant FSH and oestradiol concentration on day of HCG affect embryo development kinetics. Reprod Biomed online. 2012;25(4):382\u20139. https:\/\/doi.org\/10.1016\/j.rbmo.2012.06.016.","journal-title":"Reproductive Biomed online"},{"issue":"5","key":"2060_CR22","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.fertnstert.2009.10.044","volume":"94","author":"CM Boomsma","year":"2010","unstructured":"Boomsma CM, Kavelaars A, Eijkemans MJ, Fauser BC, Heijnen CJ, Macklon NS. Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo. Fertil Steril. 2010;94(5):1764\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.10.044.","journal-title":"Fertil Steril"},{"issue":"1","key":"2060_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s1472-6483(10)60047-8","volume":"19","author":"A Raziel","year":"2009","unstructured":"Raziel A, Schachter M, Friedler S, Ron-El R. Outcome of IVF pregnancies following severe OHSS. Reproductive Biomed online Jul. 2009;19(1):61\u20135. https:\/\/doi.org\/10.1016\/s1472-6483(10)60047-8.","journal-title":"Reproductive Biomed online Jul"},{"issue":"10","key":"2060_CR24","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1093\/humrep\/del219","volume":"21","author":"R Lahoud","year":"2006","unstructured":"Lahoud R, Al-Jefout M, Tyler J, Ryan J, Driscoll G. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF\/ICSI cycles leads to lower live birth rates. Human Reprod (Oxford England). 2006;21(10):2645\u20139. https:\/\/doi.org\/10.1093\/humrep\/del219.","journal-title":"Human Reprod (Oxford England)"},{"issue":"1","key":"2060_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12958-016-0167-8","volume":"14","author":"R Orvieto","year":"2016","unstructured":"Orvieto R, Seifer DB. Biosimilar FSH preparations- are they identical twins or just siblings? Reprod Biol Endocrinol Jun. 2016;14(1):32. https:\/\/doi.org\/10.1186\/s12958-016-0167-8.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"2060_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.rbmo.2011.11.001","volume":"24","author":"P Humaidan","year":"2012","unstructured":"Humaidan P, Papanikolaou EG, Kyrou D, et al. The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. Reproductive Biomed online. 2012;24(2):134\u201341. https:\/\/doi.org\/10.1016\/j.rbmo.2011.11.001.","journal-title":"Reproductive Biomed online"},{"issue":"Suppl 1","key":"2060_CR27","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/S1472-6483(11)60009-6","volume":"22","author":"JA Garcia-Velasco","year":"2011","unstructured":"Garcia-Velasco JA, Bennink HJ, Epifanio R, Escudero E, Pellicer A, Simon C. High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist. Reproductive Biomed online. 2011;22(Suppl 1):S52\u20139. https:\/\/doi.org\/10.1016\/S1472-6483(11)60009-6.","journal-title":"Reproductive Biomed online"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02060-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:37:01Z","timestamp":1776170221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02060-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2060"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02060-7","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Zigong Maternal and Child Health Care Hospital (Approval No. 2024IECA05). The study was a single-center retrospective analysis of previously collected, anonymized clinical data. According to institutional policies, the requirement for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}